Skip to content

Survey of Predictors of Human Papillomavirus (HPV) Vaccination Among Parents of Rural Adolescent Girls in Mysore, India

Survey of Predictors of HPV Vaccination Among Parents of Rural Adolescent Girls in Mysore, India

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01307774
Enrollment
800
Registered
2011-03-03
Start date
2014-06-30
Completion date
2015-12-31
Last updated
2014-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Human Papillomavirus

Keywords

parental acceptability of HPV vaccine

Brief summary

To conduct a quantitative survey to measure knowledge about Human papillomavirus (HPV) and cervical cancer, and HPV vaccine acceptability among parents of rural adolescent girls in Mysore District, India. Hypothesis: General knowledge and attitudes about the severity and treat ability of cancer will predict acceptability of HPV vaccination among parents of rural adolescent girls in Mysore, India.

Interventions

None listed

Sponsors

Florida International University
CollaboratorOTHER
Purnima Madhivanan
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* over 18 years of age * parent of an adolescent girl (10 -15 years of age) * able to speak English or Kannada * willing to undergo informed consent process

Exclusion criteria

* Does not have the capacity to undergo informed consent process

Design outcomes

Primary

MeasureTime frame
Parental Acceptability of HPV vaccineOne year

Secondary

MeasureTime frame
Knowledge about HPV and Cervical CancerOne Year

Countries

India

Contacts

Primary ContactVijaya Srinivas, MD
drvijaya09@gmail.com+91 821 425 9555
Backup ContactPurnima Madhivanan, MBBS, PhD
pmadhivanan2@gmail.com+91 821 425 9555

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026